Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Submitted by
admin
on June 27, 2011 - 5:53pm
Source:
Bloomberg
News Tags:
Brilinta
AstraZeneca
aspirin
Plavix
Sanofi
Bristol-Myers Squibb
Headline:
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Do Not Allow Advertisers to Use My Personal information
